Karen Annis

Efficacy and Safety of Intravenous Tanezumab for the Symptomatic Treatment of Osteoarthritis: 2 Randomized Controlled Trials versus Naproxen

Evan F. Ekman, Joseph Gimbel, Alfonso E. Bello et al. · The Journal of Rheumatology · 2014 · 86 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Effects of angiotensin-converting enzyme inhibition on transient ischemia

Carl J. Pepine, Jean‐Lucien Rouleau, Karen Annis et al. · Journal of the American College of Cardiology · 2003 · 48 citations

Medicine, Cardiology, Pharmacology +13

Efficacy and safety of crisaborole ointment, 2%, in participants aged ≥45 years with stasis dermatitis: Results from a fully decentralized, randomized, proof-of-concept phase 2a study

Jonathan I. Silverberg, Robert S. Kirsner, David J. Margolis et al. · Journal of the American Academy of Dermatology · 2024 · 16 citations · Full text

Medicine, Dermatology, Pharmacotherapy +16

Efficacy and safety of intravenous tanezumab in osteoarthritis hip and knee pain: comparison to placebo and naproxen in two phase III studies (NCT00830063 & NCT00863304)

E. Ekman, Joseph Gimbel, Akintunde Bello et al. · Journal of Pain · 2011 · 13 citations

Medicine, Pharmacology, Pharmacotherapy +10

Whole-Patient Measure of Safety: Using Administrative Data to Assess the Probability of Highly Undesirable Events During Hospitalization

Rocco J. Perla, Samuel F. Hohmann, Karen Annis · Journal for Healthcare Quality · 2013 · 10 citations

Health Professions, Health Administration, Health Services Administration +13